Brenton Mar

1 Patent

• US122524942025

  Dosing Regimens of (s)-1-(4-fluorophenyl)-1-(2-(4-(6-(1-methyl-1h-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl)piperazinyl)-pyrimidin-5-yl)ethan-1-amine for Treatment of Indolent Systemic Mastocytosis

  Blueprint Medicines Corporation

  0 cites